Tubac, Chrissel .
HRN: 29-20-49 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/20/2026
CEFUROXIME 1.5GM (VIAL)
06/20/2026
06/26/2026
IV
430MG
Q8
UTI
Checking Initial Appropriateness
06/22/2026
CEFUROXIME 750MG (VIAL)
06/22/2026
06/29/2026
IV
430mg
Q8
Acute Bacterial Inection
Checking Initial Appropriateness